Player Profile / Cyberlux Corporation

Operation Alpha: The Share Distribution Network

Complete OTC Issuance Record · 2021–2022 · ~1.6 Billion Shares · 30+ Named Recipients

Operation Alpha is Cyberlux's own term. It appears in the company's annual report as the vehicle for its expansion strategy — acquisitions, BD relationships, and promotional infrastructure. The term also appears in the Rosen indictment context, where it coincides with the period of the charged securities fraud conspiracy. The overlap between those two uses of the same name, in the same company, in the same time window, is the central analytical question this page documents.

Bottom Line

What this profile says up front

01
Cyberlux Corporation's OTC annual filings document the issuance of approximately 1.6 billion common shares to more than thirty named individuals and entities between mid-2021 and end-2022 — the period Cyberlux's own annual report identifies as 'Operation Alpha,' its stated expansion strategy.
02
The issuance record divides into four analytically distinct groups: a coordinated Stock Purchase Agreement cohort of 15 individuals receiving identical 20.8 million-share tranches at $0.0012; entities explicitly compensated for PR and sales representation services; the Rosen/RB Capital financing layer (predominantly unrestricted shares, freely tradeable at issuance); and advisory board, executive, and legal service recipients.
03
The coordinated SPA cohort — including William Ferrell (@WTF_OS), Priyanka Saxena, Salahuddin Siddiq, Clay DeNicola, and Matt Rivett among others — received a combined ~473 million restricted shares at $0.0012, all on the same dates in coordinated tranches. Ferrell is the only member of this cohort publicly identified as a paid promoter; the promotional status of the others is not established in any public filing.
04
The Rosen/RB Capital layer received approximately 450 million unrestricted shares — freely sellable immediately — through debt purchase agreements. The Rosen indictment covers a conspiracy period beginning August 10, 2020, encompassing the entire Operation Alpha issuance window, with Cyberlux named as one of six charged issuers.
Role in the Record

Operation Alpha is Cyberlux's own term. It appears in the company's annual repor...

Operation Alpha is Cyberlux's own term. It appears in the company's annual report as the vehicle for its expansion strategy — acquisitions, BD relationships, and promotional infrastructure. The term also appears in the Rosen indictment context, where it coincides with the period of the charged securities fraud conspiracy. The overlap between those two uses of the same name, in the same company, in the same time window, is the central analytical question this page documents.

The OTC annual filings are primary documents — Cyberlux's own regulatory disclosures to OTC Markets. They record who received shares, how many, at what price, on what basis, and whether those shares were restricted or freely tradeable. The table below contains every material issuance from the mid-2021 through end-2022 period as filed. The categorisation is analytical; it reflects the filing's own basis description.

What the record shows is a company that, during a two-year window, issued shares to: a coordinated network of individual stock purchasers at a fraction of a penny per share; entities explicitly retained for public relations and sales representation; a financing firm subsequently charged by the DOJ and SEC with securities fraud and money laundering; and its advisory board, legal counsel, and executives. Whether those activities were coordinated, and toward what end, is a question the record raises and discovery would need to answer.

Key Numbers

The numbers that frame the profile

Total shares documented
~1.6B
FY2022–FY2023 OTC filings
Named recipients
30+
Across 4 analytical groups
SPA cohort (Group A)
~473M
15 recipients · $0.0012 · restricted
RB Capital layer (unrestricted)
~450M
Freely tradeable at issuance
Cyberlux's term for the period
Operation Alpha
Per company annual report
Rosen conspiracy period
Aug 2020–Oct 2024
Encompasses full issuance window
Source Tables

Documented source record

Source table

Name / Entity Shares $/share Date(s) Filed Basis Restricted
GROUP A — Stock Purchase Agreements · coordinated tranches · $0.0012 · restricted
William Ferrell @WTF_OS 83,333,332 $0.0012 Jul 21 ×2, Oct 8, Jan 7 2022 Stock Purchase Agreement Yes
Priyanka Saxena 93,333,333 $0.0012 Jul 27, Aug 23 ×2, Oct 8, Jan 7 2022 Stock Purchase Agreement Yes
Salahuddin Siddiq 62,499,999 $0.0012 Jul 21, Oct 8, Jan 7 2022 Stock Purchase Agreement Yes
Clay DeNicola 62,499,999 $0.0012 Jul 21, Oct 8, Jan 7 2022 Stock Purchase Agreement Yes
Matt Rivett 62,499,999 $0.0012 Aug 23 ×2, May 5 2022 Stock Purchase Agreement Yes
David McClintock 20,833,333 $0.0012 Jul 21, 2021 Stock Purchase Agreement Yes
Colin Udvig 20,833,333 $0.0012 Jul 21, 2021 Stock Purchase Agreement Yes
Christopher Fulkerson 20,833,333 $0.0012 Jul 21, 2021 Stock Purchase Agreement Yes
Sameer Jain & Deepika Jain JTWORS 20,833,333 $0.0012 Aug 23, 2021 Stock Purchase Agreement Yes
Charles Coote Jr. 6,153,846 $0.0012 Jul 21, 2021 Stock Purchase Agreement Yes
Ronald Corlew 6,384,615 $0.0012 Jul 21, Oct 8, 2021 Stock Purchase Agreement Yes
Wynn-Jones Revocable Trust / Robert Wynn 5,384,615 $0.0012 Jul 21, 2021 Stock Purchase Agreement Yes
Ronald Childs 3,703,704 $0.0012 Sep 2, 2021 Stock Purchase Agreement Yes
Alvin Campbell 1,851,852 $0.0012 Oct 13, 2021 Stock Purchase Agreement Yes
Robert E. Dawson Jr. 2,307,692 $0.0012 Jul 21, 2021 Stock Purchase Agreement Yes
Group A total ~473,052,943 $0.0012 All restricted · 15 named recipients
GROUP B — Explicitly labeled PR / promotional / sales representation services
Brennan Smith / Flying V Group PR SERVICES 2,000,000 $0.01 Dec 27, 2021 Public Relations Services Terms Yes
North Equities USA / Ernest Chuang PR SERVICES 5,882,353 $0.01 Mar 16, 2022 Public Relations Services Terms Yes
Anthony Gonzalez 2,000,000 $0.001 Mar 18, 2022 Sales Representation Agreement Terms Yes
Strike Group LLC / Lane Coleman 1,000,000 $0.01 Oct 15, 2021 Sales Representation Agreement Terms Yes
Group B total 10,882,353 Explicitly compensated for PR/sales services · all restricted
GROUP C — Financing layer (Rosen / RB Capital + related) · largely unrestricted
RB Capital Partners / Brett & Deborah Rosen UNRESTRICTED 450,000,000 $0.001 Oct 21, Nov 10, Aug 15 2022 Debt Purchase Agreement No (unrestricted)
Montague Capital Partners / Denis Kalenja UNRESTRICTED 200,000,000 $0.001 Nov 3, 2021 Debt Settlement No (unrestricted)
Roman Investments PR LLC / Roman Vinfield PARTLY UNREST. ~119,200,000 mixed Nov 8, Nov 22, Dec 6, 2022 Debt Purchase + Stock Purchase Partly no
Rosewood Theater LLC / Michael Sinensky 15,000,000 $0.0025 Nov 8, 2022 Stock Purchase Agreement Yes
Rock Bay Partners / Alston Gardner UNRESTRICTED 27,637,500 $0.022 Nov 9, 2021 Debt Settlement / Fulcrum Advisors No (unrestricted)
Group C total ~811,837,500 Predominantly unrestricted · freely tradeable at issuance
GROUP D — Advisory board, executive, legal roles with documented positions
Aaron Goodman BOARD 70,000,000 mixed Dec 28, 2021 + Dec 22, 2022 Board of Directors Agreement + SPA Yes
William L. Welter III Trust LEGAL 70,000,000 $0.002 Sep 16, 2021 Debt Settlement Legal Fees Yes
Charles D. Watts LEGAL · NAMED DEF. 60,384,615 $0.01 Jul 14, Jul 21, Oct 8, 2021 Debt Settlement Legal Fees Yes
Cameron Holt, Maj Gen USAF (Ret.) ADVISORY BD 10,000,000 $0.001 Dec 27, 2022 Advisory Board Agreement Terms Yes
Martin Moore ADVISORY BD 10,000,000 $0.001 Dec 27, 2022 Advisory Board Agreement Terms Yes
Robert Bret Velicovich ADVISORY BD 10,000,000 $0.001 Dec 27, 2022 Advisory Board Agreement Terms Yes
Michael N. Porter 20,000,000 $0.001 Dec 27, 2022 Employment Agreement Terms Yes
Alvaro Zuluaga 10,000,000 $0.001 Aug 4, 2021 Executive Management Incentive Yes
Tyrone Everett 10,000,000 $0.001 Aug 23, 2021 Debt Settlement Yes
Ben Eberdt 20,000,000 $0.01 Jul 12, 2021 Debt Settlement Yes
Group D total ~290,384,615 Named roles documented in filings
AGGREGATE (Groups A–D) ~1,586,157,411 All issuances documented in FY2022 and FY2023 OTC annual filings
Analytical Findings

What the record establishes

01 BEDROCK

The OTC filing record: 30+ named recipients across 4 groups

The Cyberlux FY2022 and FY2023 OTC annual filings document the complete issuance record reproduced in the table above. Every entry is as filed — name, share count, price per share, date, stated basis, and restricted/unrestricted status. The filings are public regulatory documents. The record is not in dispute.

Source: Cyberlux FY2022 OTC Annual Report · Cyberlux FY2023 OTC Annual Report · OTC Markets shareholder issuance recordSource:
02 BEDROCK

Operation Alpha: Cyberlux's own term for the period

Cyberlux's annual report uses the term 'Operation Alpha' to describe its stated expansion strategy during this period — acquisitions, growth initiatives, and what the company characterised as business development. The same term appears in the promotional and coverage record as describing the vehicle for $CYBL's OTC investor narrative amplification. The company's own labelling of this period is the starting point for understanding the share distribution architecture.

Source: Cyberlux OTC Annual Report (Operation Alpha reference) · Prior Jackson Holt coverage · Rosen indictment contextSource:
03 BEDROCK

The coordinated SPA tranche pattern

The Group A SPA cohort received shares in identical 20,833,333-unit blocks on three concentrated dates: July 21, 2021 (nine recipients, including Ferrell ×2, Siddiq, DeNicola, McClintock, Udvig, Fulkerson, Coote, Corlew, Dawson, Wynn); August 23, 2021 (Saxena ×2, Rivett ×2, Jain); October 8, 2021 (Saxena, Ferrell, Siddiq, DeNicola, Corlew); and January 7, 2022 (Saxena, Ferrell, Siddiq, DeNicola). Same block size, same price, same dates — across fifteen individuals. This is not a pattern consistent with arm's-length market transactions.

Source: Cyberlux FY2022 OTC Annual Report · Cyberlux FY2023 OTC Annual ReportSource:
04 BEDROCK

The unrestricted layer: 450M shares to Rosen, freely tradeable

RB Capital Partners (Brett Rosen/Deborah Rosen) received three tranches of unrestricted shares: 125M on October 21, 2021; 125M on November 10, 2021; and 200M on August 15, 2022. All were unrestricted — meaning they could be sold into the market immediately upon receipt. The Rosen indictment covers a conspiracy period of August 10, 2020 to October 14, 2024. Cyberlux is named as one of six charged issuers. The two October and November 2021 issuances sit inside the charged conspiracy window.

Source: Cyberlux FY2022 OTC Annual Report · U.S. v. Rosen et al., 3:26-cr-00192-DMS · Indictment, charged periodSource:
05 ROCK

PR and sales representation: the explicitly compensated promotional layer

Four entities received shares explicitly for public relations or sales representation services: Flying V Group/Brennan Smith (2M, Dec 27, 2021, 'Public Relations Services Terms'); North Equities USA/Ernest Chuang (5.88M, Mar 16, 2022, 'Public Relations Services Terms'); Anthony Gonzalez (2M, Mar 18, 2022, 'Sales Representation Agreement Terms'); and Strike Group/Lane Coleman (1M, Oct 15, 2021, 'Sales Representation Agreement Terms'). These are the promotional layer the filing itself labels as such.

Source: Cyberlux FY2022 OTC Annual Report · Cyberlux FY2023 OTC Annual ReportSource:
06 BEDROCK

Cameron Holt's 10M shares: December 27, 2022

The FY2022 OTC annual filing documents the issuance of 10,000,000 common shares to Cameron Holt, Maj Gen, USAF (Ret.) on December 27, 2022, under 'Advisory Board Agreement Terms.' This entry confirms Holt's equity compensation from Cyberlux — shares issued as consideration for advisory board service. This issuance occurs after the August 31, 2022 retirement date that marks his transition from the Air Force to Holt Consulting Group and the Cyberlux advisory board.

Source: Cyberlux FY2022 OTC Annual Report (Dec 27, 2022 issuance entry)Source:
07 ROCK

Section 17(b) and the undisclosed holdings question across the SPA cohort

Section 17(b) of the Securities Act prohibits promotional activity in connection with a security without disclosing compensation received. The SPA cohort members collectively held approximately 473 million shares at $0.0012 — a position that benefits from stock price increases. Ferrell is the only member of the cohort publicly identified as engaging in promotional activity. Whether any other SPA cohort member engaged in $CYBL promotional activity on any platform, while holding undisclosed share positions, is not established in any public filing but is a question the pattern raises.

Source: Securities Act of 1933, § 17(b) · Curtin Supplemental Declaration · OTC platform recordSource:
Open Questions

What the record does not explain

Q01
What was the commercial basis for the coordinated distribution of identical 20,833,333-share blocks to fifteen individuals across three concentrated dates? Were these arms'-length purchases at $0.0012, or were the shares compensatory in nature labeled as purchases?
Q02
Did any member of the Group A SPA cohort — beyond Ferrell — engage in promotional activity for $CYBL on any platform, while holding shares they had not disclosed?
Q03
Did the Group B PR and sales representation recipients (Flying V, North Equities, Gonzalez, Coleman) produce promotional content for $CYBL, and if so, was their share compensation disclosed in that content?
Q04
Were any of the Group A or Group B shares subsequently sold by their recipients, and if so, on what timeline and at what price relative to promotional activity?
Q05
What was the relationship between the SPA cohort and the RB Capital/Rosen financing layer — were they coordinated within the same Operation Alpha structure?
Q06
Cameron Holt received 10 million shares on December 27, 2022. Did his advisory activities for Cyberlux extend to any communications with government officials about the HII subcontract, and were those communications made while holding an undisclosed equity position?
Q07
Has the SEC or DOJ examined the Group A SPA distribution pattern in connection with the Rosen investigation, given that Cyberlux is a named issuer in the charged conduct?
Q08
Who at Cyberlux authorised and executed the coordinated SPA distribution — Schmidt, Downing, or another officer — and what internal documentation exists for the commercial rationale?